Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Salazar F et al. | Renal effects induced by prolonged mPGES1 inhibition. | 2014 | Am. J. Physiol. Renal Physiol. | pmid:24197070 |
Lee HI et al. | Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. | 2014 | Pharmacogenet. Genomics | pmid:24322170 |
Voisin V et al. | Protection of Wistar-Furth rats against postischaemic acute renal injury: role for nitric oxide and thromboxane? | 2014 | Clin. Exp. Pharmacol. Physiol. | pmid:25115485 |
Hong S et al. | Maresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages. | 2014 | Chem. Biol. | pmid:25200603 |
Tong B et al. | [Atorvastatin inhibits platelet aggregation and activation following carotid balloon injury in cholesterol-fed rabbits]. | 2014 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:25176087 |
Kaplon-Cieslicka A et al. | Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study. | 2014 | Cardiovasc Diabetol | pmid:25123549 |
Hayashi G et al. | Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia. | 2014 | Hum. Mol. Genet. | pmid:25104852 |
Hill TL et al. | The effect of tramadol and indomethacin coadministration on gastric barrier function in dogs. | 2014 May-Jun | J. Vet. Intern. Med. | pmid:24684670 |
Zhou Z et al. | Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors. | 2015 | Vascul. Pharmacol. | pmid:25921923 |
Larsen SB et al. | Calprotectin and platelet aggregation in patients with stable coronary artery disease. | 2015 | PLoS ONE | pmid:25970343 |
Lourenço AL et al. | Synthesis and antiplatelet activity of antithrombotic thiourea compounds: biological and structure-activity relationship studies. | 2015 | Molecules | pmid:25903367 |
Sahota T et al. | Model-based prediction of the acute and long-term safety profile of naproxen in rats. | 2015 | Br. J. Pharmacol. | pmid:25884765 |
Violi F et al. | Reply: platelet activation and pneumonia: is soluble p-selectin the right marker? | 2015 | J. Am. Coll. Cardiol. | pmid:25857924 |
Gurbel PA et al. | Platelet activation and pneumonia: is soluble p-selectin the right marker? | 2015 | J. Am. Coll. Cardiol. | pmid:25857923 |
Violi F et al. | Reply: myocardial infarction in patients with pneumonia. | 2015 | J. Am. Coll. Cardiol. | pmid:25857922 |
Savas G and Kalay N | Myocardial infarction in patients with pneumonia. | 2015 | J. Am. Coll. Cardiol. | pmid:25857921 |
Voon PT et al. | Virgin olive oil, palm olein and coconut oil diets do not raise cell adhesion molecules and thrombogenicity indices in healthy Malaysian adults. | 2015 | Eur J Clin Nutr | pmid:25804278 |
Karamouzis I et al. | Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. | 2015 | Clin. Endocrinol. (Oxf) | pmid:24923553 |
Willenberg I et al. | Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E(2), D(2) and thromboxane B(2). | 2015 | J Chromatogr A | pmid:25777050 |
Wang J et al. | Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats. | 2015 | BMC Complement Altern Med | pmid:25886942 |